These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33254484)

  • 1. Methylene blue may have a role in the treatment of COVID-19.
    Ghahestani SM; Shahab E; Karimi S; Madani MH
    Med Hypotheses; 2020 Nov; 144():110163. PubMed ID: 33254484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial.
    Mansour E; Bueno FF; de Lima-Júnior JC; Palma A; Monfort-Pires M; Bombassaro B; Araujo EP; Bernardes AF; Ulaf RG; Nunes TA; Ribeiro LC; Falcão ALE; Santos TM; Trabasso P; Dertkigil RP; Dertkigil SS; Maia RP; Benaglia T; Moretti ML; Velloso LA
    Trials; 2021 Jan; 22(1):71. PubMed ID: 33472675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
    Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
    Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?
    Gouda AS; Mégarbane B
    Drug Dev Res; 2021 Feb; 82(1):38-48. PubMed ID: 32761647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue restores vasodilation to bradykinin after inhibition of nitric oxide production in the isolated dog lung.
    Shapiro MB; Endredi J; Ehrhart IC; Hofman WF
    J Vasc Res; 1996; 33(4):340-5. PubMed ID: 8695758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.
    Desta B; Nakashima M; Kirchengast M; Vanhoutte PM; Boulanger CM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):885-91. PubMed ID: 7531766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
    Ghahestani SM; Mahmoudi J; Hajebrahimi S; Sioofy-Khojine AB; Salehi-Pourmehr H; Sadeghi-Ghyassi F; Mostafaei H
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):13-17. PubMed ID: 32534506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
    Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
    Front Immunol; 2020; 11():2014. PubMed ID: 32849666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.
    de Maat S; de Mast Q; Danser AHJ; van de Veerdonk FL; Maas C
    Semin Thromb Hemost; 2020 Oct; 46(7):835-837. PubMed ID: 32526773
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
    Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
    Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a possible role of the brain kallikrein-kinin system in the modulation of the cerebral circulation.
    Kamitani T; Little MH; Ellis EF
    Circ Res; 1985 Oct; 57(4):545-52. PubMed ID: 2412721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of biologically active kinin peptides, Met-Lys-bradykinin and Leu-Met-Lys-bradykinin from human kininogens by two major secreted aspartic proteases of Candida parapsilosis.
    Bras G; Bochenska O; Rapala-Kozik M; Guevara-Lora I; Faussner A; Kamysz W; Kozik A
    Peptides; 2013 Oct; 48():114-23. PubMed ID: 23954712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
    Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
    Siragy HM; Jaffa AA; Margolius HS
    Hypertension; 1997 Mar; 29(3):757-62. PubMed ID: 9052892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of bradykinin-induced cyclic GMP accumulation in bovine tracheal smooth muscle.
    Sheng H; Ishii K; Förstermann U; Murad F
    Lung; 1995; 173(6):373-83. PubMed ID: 8531500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Life-Threatening ACE-Inhibitor-Induced Angioedema.
    Hirschy R; Shah T; Davis T; Rech MA
    Adv Emerg Nurs J; 2018; 40(4):267-277. PubMed ID: 30365440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase.
    Luo D; Das S; Vincent SR
    Eur J Pharmacol; 1995 Aug; 290(3):247-51. PubMed ID: 7589219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene blue for distributive shock: a potential new use of an old antidote.
    Jang DH; Nelson LS; Hoffman RS
    J Med Toxicol; 2013 Sep; 9(3):242-9. PubMed ID: 23580172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.